Efficacy of Aflibercept for the treatment of diabetic macular oedema in patients refractory to Ranibizumab

被引：0
|
作者：
Clarke, Holly [1 ]
Sepetis, Anastasios [1 ]
Rennie, Christina [1 ]
Lotery, Andrew [1 ]
Sahu, Debendra [1 ]
Inzerillo, Dario [1 ]
Gupta, Bhaskar [1 ]
机构：
[1] Univ Hosp Southampton, Southampton, Hants, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3606
引用
收藏
页数：3
相关论文
共 50 条
  • [1] OUTCOMES OF SWITCHING TREATMENT TO AFLIBERCEPT IN PATIENTS WITH DIABETIC MACULAR OEDEMA REFRACTORY TO RANIBIZUMAB
    Konidaris, V. E.
    Tsaousis, K. T.
    Al-Hubeshy, Z.
    Pieri, K.
    Deane, J.
    Empeslidis, T.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (02) : E84 - E84
  • [2] Faricimab for Diabetic Macular Edema in Patients Refractory to Ranibizumab or Aflibercept
    Ohara, Hiromi
    Harada, Yosuke
    Hiyama, Tomona
    Sadahide, Ayako
    Minamoto, Akira
    Kiuchi, Yoshiaki
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [3] Efficacy of Ranibizumab Therapy with Aflibercept in Patients with Diabetic Macular Edema
    Teixeira, Leonardo Pinheiro
    Dalia, Eduardo
    Campos, Luana
    Abrahao, Mayara Martins
    Nassaralla, Joao J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [4] Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
    Vandekerckhove, Kristof R. O. A.
    INTERNATIONAL OPHTHALMOLOGY, 2015, 35 (04) : 603 - 609
  • [5] Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
    Kristof ROA Vandekerckhove
    International Ophthalmology, 2015, 35 : 603 - 609
  • [6] Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab
    Konidaris, Vasileios
    Al-Hubeshy, Zahra
    Tsaousis, Konstantinos T.
    Gorgoli, Konstantina
    Banerjee, Somnath
    Empeslidis, Theodoros
    INTERNATIONAL OPHTHALMOLOGY, 2018, 38 (01) : 207 - 213
  • [7] Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab
    Vasileios Konidaris
    Zahra Al-Hubeshy
    Konstantinos T. Tsaousis
    Konstantina Gorgoli
    Somnath Banerjee
    Theodoros Empeslidis
    International Ophthalmology, 2018, 38 : 207 - 213
  • [8] The Efficacy of Aflibercept in the Management of Treatment-Resistant Diabetic Macular Oedema
    Bahrami, Bobak
    Ewe, Shaun
    Hong, Thomas
    Zhu, Meidong
    Peto, Tunde
    Levente, Toth
    Wong, James
    Chang, Andrew
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 24 - 24
  • [9] Clinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular oedema
    Konidaris, V. E.
    Tsaousis, K. T.
    Al-Hubeshy, Z.
    Pieri, K.
    Deane, J.
    Empeslidis, T.
    EYE, 2017, 31 (11) : 1629 - 1630
  • [10] Clinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular oedema
    V E Konidaris
    K T Tsaousis
    Z Al-Hubeshy
    K Pieri
    J Deane
    T Empeslidis
    Eye, 2017, 31 : 1629 - 1630
12345